# Flamengo's Goal Data and Analysis: How Did They Perform in the Last Season?
## Goal Scoring: A Key Strength for Flamengo
Flamengo demonstrated exceptional attacking prowess in the last season, finishing as one of the top scorers in the league. With a total of 75 goals scored in 38 matches, the team showcased its ability to consistently find the back of the net. Their average of nearly 2 goals per game highlighted their attacking efficiency and creativity in the final third. Flamengo's goals were evenly distributed across open play, set-pieces, and penalties, indicating a well-rounded attacking strategy.
## Defensive Performance: A Mixed Bag
While Flamengo's attack was a standout feature, their defensive performance was less consistent. The team conceded 43 goals, resulting in a goal difference of +32, which is impressive but also reveals room for improvement. Flamengo kept 12 clean sheets throughout the season, but they occasionally struggled against teams that exploited their defensive vulnerabilities, particularly from set-pieces.
## Key Players: Driving Force Behind the Numbers
The success of Flamengo's attack was heavily influenced by their star forwards. Pedro and Gabriel Barbosa were the standout performers, contributing 25 and 22 goals respectively. Their chemistry on the field and ability to create chances out of nothing were instrumental in Flamengo's high goal tally. Midfielders like De Arrascaeta also played a crucial role, providing assists and controlling the tempo of the game.
## Overall Performance and Future Prospects
Flamengo's goal data reflects a season of dominance and entertainment. While their attacking brilliance often overshadowed defensive lapses, the team's ability to outscore opponents was a key factor in securing a top-four finish in the league and a deep run in the Copa Libertadores. Moving forward, addressing defensive frailties will be crucial for Flamengo to achieve even greater success in the upcoming season. For now, fans can celebrate a campaign filled with thrilling moments and clinical finishing.